Stem Cell Institute of America, LLC

Last Updated:
Case Status:
Pending
Federal Trade Commission and State of Georgia, Plaintiffs, v. Steven D. Peyroux, individually and as an owner and officer of Regenerative Medicine Institute of America, LLC, also d/b/a Stem Cell Institute of America, LLC, Physicians Business Solutions, LLC, and Superior Healthcare, LLC, Brent J. Detelich, Individually and as an officer of Regenerative Medicine Institute of America, LLC, also d/b/a Stem Cell Institute of America, LLC, Regenerative Medicine Institute of America, LLC, a limited liability company, also d/b/a Stem Cell Institute of America, LLC, Physicians Business Solutions, LLC, a limited liability company, and Superior Healthcare, LLC, a limited liability company, Defendants.
FTC Matter/File Number:

182 3125

Civil Action Number:

1:21-cv-03329-AT

Federal Court:
Northern District of Georgia

Case Summary

In August 2021, the FTC and the Georgia Attorney General’s Office sued the co-founders of the Stem Cell Institute of America for marketing stem cell therapy to seniors nationwide using bogus claims that it is effective in treating arthritis, joint pain, and a range of other orthopedic ailments.